+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pruritus Therapeutics Market by Therapy (Antihistamines, Biologics, Calcineurin inhibitors), Route of Administration (Injectable, Oral, Topical), Disease Indication, Patient Demographics, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Pruritus Therapeutics Market by Therapy (Antihistamines, Biologics, Calcineurin inhibitors), Route of Administration (Injectable, Oral, Topical), Disease Indication, Patient Demographics, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image
Sale

Pruritus Therapeutics Market by Therapy (Antihistamines, Biologics, Calcineurin inhibitors), Route of Administration (Injectable, Oral, Topical), Disease Indication, Patient Demographics, Distribution Channel, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888867
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Strategic innovation and evolving patient needs are redefining the pruritus therapeutics market, creating new opportunities for industry stakeholders to optimize product pipelines, enhance operational efficiencies, and respond to regulatory changes impacting global supply chains.

Market Snapshot: Pruritus Therapeutics Market Overview

The Pruritus Therapeutics Market grew from USD 5.93 billion in 2024 to USD 6.24 billion in 2025. It is expected to continue growing at a CAGR of 5.47%, reaching USD 8.17 billion by 2030.

Market expansion reflects sustained advancements in biologics, responsive go-to-market strategies, and an increasingly sophisticated regulatory environment. Digital health platforms and patient engagement technologies further enable stakeholders to capture value in a complex treatment landscape.

Scope & Segmentation

This report delivers in-depth analysis across the full pruritus therapeutics continuum. Key segmentation points include:

  • Therapy Classes: Antihistamines, Biologics, Calcineurin inhibitors, Corticosteroids, Immunosuppressants.
  • Route of Administration: Injectable, Oral, Topical.
  • Disease Indication: Allergic Contact Dermatitis, Atopic Dermatitis, Cutaneous T-cell, Urticaria.
  • Patient Demographics: Adult Patients, Geriatric Patients, Pediatric Patients.
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
  • End Users: Clinics, Dermatology Centers, Homecare Settings, Hospitals.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—including major markets in United States (with state-level granularity), Canada, Latin America, UK, Germany, France, China, India, Japan, Australia, and Southeast Asia.
  • Companies Profiled: A comprehensive set of leading and emerging players including AbbVie Inc., Bayer AG, Cara Therapeutics Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., among others.

Coverage includes current therapy adoption, emerging technology platforms, and dynamics shaping regional demand.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Rapid innovation in biologics and targeted therapies is displacing traditional treatments in both hospital and outpatient settings.
  • Digital health tools are contributing to real-world data collection, informing personalized treatment approaches and accelerating market validation.
  • Collaborative models between academia and industry are driving translational research, shortening time to market for novel interventions.
  • Patient-centric healthcare is shaping trial designs, distribution strategies, and formulary access decisions.
  • Contract development and manufacturing organizations are expanding capacity for specialized formulations, supporting agile supply chain responses.
  • Adaptive reimbursement models are emerging in response to evolving regulatory standards and complex value-based negotiations.

Tariff Impact

The 2025 changes to United States tariff schedules have caused pronounced shifts in supply chain management, price structuring, and cross-border investments for pruritus therapeutics. Companies are reevaluating production locations and renegotiating supplier agreements to reduce exposure to tariff-related cost increases and operational disruptions. Diversification of supply chains and scenario planning are becoming standard practice. Healthcare providers and payers are tracking pricing trends closely, with payer formulary changes influencing patient access and therapy utilization.

Research Methodology & Data Sources

The study employs a rigorous approach integrating primary research from expert interviews and validated secondary sources, including peer-reviewed literature, regulatory documents, and industry white papers. Analytical tools such as SWOT analysis and scenario planning support a robust and transparent research process.

Why This Report Matters

  • Enables decision-makers to anticipate emerging opportunities and mitigate supply chain and regulatory risks across diverse global markets.
  • Supports strategic prioritization by mapping key therapy segments, patient populations, and regional commercial dynamics.
  • Enhances due diligence for investment planning by profiling competitive activity, innovation pipelines, and partnership trends shaping sector leadership.

Conclusion

The pruritus therapeutics market is evolving rapidly, driven by scientific advancements and regulatory shifts. Leaders who align operational strategies with regional trends and technology adoption will be best positioned to capture growth and deliver patient value in a complex competitive landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of IL-31 receptor-targeting monoclonal antibodies for refractory atopic pruritus relief
5.2. Integration of real-world evidence in evaluating long-term safety of JAK inhibitors for chronic itch
5.3. Advancements in topical cannabinoid formulations for managing neuropathic itch associated with eczema
5.4. Growth of biosimilar launches for established pruritus biologics to improve patient access and affordability
5.5. Increasing use of digital health tools for continuous monitoring and personalized management of severe itching
5.6. Expansion of prurigo nodularis pipeline with peptide modulators targeting neural itch signaling pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pruritus Therapeutics Market, by Therapy
8.1. Introduction
8.2. Antihistamines
8.3. Biologics
8.4. Calcineurin inhibitors
8.5. Corticosteroids
8.6. Immunosuppressant
9. Pruritus Therapeutics Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Pruritus Therapeutics Market, by Disease Indication
10.1. Introduction
10.2. Allergic Contact Dermatitis
10.3. Atopic Dermatitis
10.4. Cutaneous T-cell
10.5. Urticaria
11. Pruritus Therapeutics Market, by Patient Demographics
11.1. Introduction
11.2. Adult Patients
11.3. Geriatric Patients
11.4. Pediatric Patients
12. Pruritus Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Pruritus Therapeutics Market, by End-User
13.1. Introduction
13.2. Clinics
13.3. Dermatology Centers
13.4. Homecare Settings
13.5. Hospitals
14. Americas Pruritus Therapeutics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Pruritus Therapeutics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Pruritus Therapeutics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Asana BioSciences, LLC
17.3.3. Astellas Pharma Inc.
17.3.4. Avior Bio Inc.
17.3.5. Bausch Health Companies Inc.
17.3.6. Bayer AG
17.3.7. Cara Therapeutics Inc.
17.3.8. Eli Lilly and Company
17.3.9. EPI Health LLC by Novan, Inc.
17.3.10. Escient Pharmaceuticals by Incyte Corporation
17.3.11. Evelo Biosciences, Inc.
17.3.12. Galderma S.A.
17.3.13. GlaxoSmithKline plc
17.3.14. LEO Pharma A/S
17.3.15. Mallinckrodt plc
17.3.16. MC2 Therapeutics A/S
17.3.17. Mirum Pharmaceuticals, Inc.
17.3.18. NeRRe Therapeutics Ltd
17.3.19. Novartis AG
17.3.20. Pfizer Inc.
17.3.21. Regeneron Pharmaceuticals, Inc.
17.3.22. Sanofi S.A.
17.3.23. Teva Pharmaceutical Industries Ltd.
17.3.24. Toray Industries, Inc.
17.3.25. Trevi Therapeutics, Inc
17.3.26. Vanda Pharmaceuticals Inc.
17.3.27. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PRURITUS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PRURITUS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PRURITUS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PRURITUS THERAPEUTICS MARKET: RESEARCHAI
FIGURE 28. PRURITUS THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. PRURITUS THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 30. PRURITUS THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PRURITUS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ALLERGIC CONTACT DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ALLERGIC CONTACT DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CUTANEOUS T-CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CUTANEOUS T-CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 94. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 95. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 100. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 101. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 106. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 107. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 168. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 169. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 174. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 175. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 179. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 180. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 181. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 186. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 187. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. FRANCE PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 204. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 205. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 210. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 211. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. ITALY PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 216. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 217. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 222. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 223. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. SPAIN PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 262. SOUTH AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 263. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 264. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 265. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 270. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 271. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. DENMARK PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 287. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 288. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 289. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 294. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 295. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. QATAR PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 300. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 301. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 306. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 307. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 310. FINLAND PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 322. SWEDEN PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025-2030 (U

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pruritus Therapeutics market report include:
  • AbbVie Inc.
  • Asana BioSciences, LLC
  • Astellas Pharma Inc.
  • Avior Bio Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cara Therapeutics Inc.
  • Eli Lilly and Company
  • EPI Health LLC by Novan, Inc.
  • Escient Pharmaceuticals by Incyte Corporation
  • Evelo Biosciences, Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Mallinckrodt plc
  • MC2 Therapeutics A/S
  • Mirum Pharmaceuticals, Inc.
  • NeRRe Therapeutics Ltd
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Industries, Inc.
  • Trevi Therapeutics, Inc
  • Vanda Pharmaceuticals Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.17 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Pruritus Therapeutics Market Report 2025 - Product Image

Pruritus Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Chronic Pruritus Therapeutics Global Market Report 2025 - Product Image

Chronic Pruritus Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Pruritus Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pruritus Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 132 Pages
  • Global
From

About the Pruritus Drug Market

Pruritus, or itching, is a common symptom of many skin conditions and can be treated with dermatological drugs. These drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and can include corticosteroids, calcineurin inhibitors, and antihistamines. Systemic drugs are taken orally or injected and can include anticonvulsants, antidepressants, and opioids. The pruritus drug market is a subset of the larger dermatological drug market. It is composed of a variety of drugs used to treat itching, including both topical and systemic treatments. These drugs are used to treat a wide range of skin conditions, from eczema and psoriasis to allergic reactions and insect bites. Some companies in the pruritus drug market include Pfizer, Novartis, GlaxoSmithKline, Sanofi, and Merck. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.